Biocon Limited reported earnings results for the fourth quarter ended March 31, 2022. For the fourth quarter, the company reported sales was INR 24,088 million compared to INR 18,421 million a year ago. Revenue was INR 24,761 million compared to INR 20,475 million a year ago. Net income was INR 2,386 million compared to INR 2,532 million a year ago. Basic earnings per share from continuing operations was INR 2 compared to INR 2.13 a year ago. Diluted earnings per share from continuing operations was INR 1.99 compared to INR 2.12 a year ago.